  |
Lægemiddelstofklassifikation ATC |
M | ||
 |
Antineoplastiske og immunomodulerende midler |
ML | ||
  |
immunsuppressiva |
ML04 | ||
 |
immunsuppressiva |
ML04A | ||
|
selektive immunsuppressiva |
ML04AA | ||
|
tumor necrosis factor alpha (TNF-alfa) hæmmere |
ML04AB | ||
|
interleukinhæmmere |
ML04AC | ||
|
calcineurinhæmmere |
ML04AD | ||
|
sphingosin 1-phosphat (S1P) receptormodulatorer |
ML04AE | ||
|
janus associerede kinase (JAK) hæmmere |
ML04AF | ||
|
monoklonale antistoffer |
ML04AG | ||
|
mammalian target of rapamycin (mTOR) kinasehæmmere |
ML04AH | ||
|
komplementhæmmere |
ML04AJ | ||
|
dihydroorotat dehydrogenase (DHODH) hæmmere |
ML04AK | ||
|
neonatal fragment crystallizable receptor (FcRn) hæmmere |
ML04AL | ||
|
andre immunosuppressiva |
ML04AX |
TEXT